Annual Retained Earnings
-$69.57 M
-$18.85 M-37.17%
31 December 2023
Summary:
CNS Pharmaceuticals annual retained earnings is currently -$69.57 million, with the most recent change of -$18.85 million (-37.17%) on 31 December 2023. During the last 3 years, it has fallen by -$48.62 million (-232.12%). CNSP annual retained earnings is now -31607.79% below its all-time high of -$219.40 thousand, reached on 31 December 2017.CNSP Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Retained Earnings
-$81.25 M
-$5.61 M-7.41%
30 September 2024
Summary:
CNS Pharmaceuticals quarterly retained earnings is currently -$81.25 million, with the most recent change of -$5.61 million (-7.41%) on 30 September 2024. Over the past year, it has dropped by -$17.06 million (-26.57%). CNSP quarterly retained earnings is now -967.47% below its all-time high of -$7.61 million, reached on 31 December 2018.CNSP Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CNSP Retained Earnings Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -37.2% | -26.6% |
| 3 y3 years | -232.1% | -152.4% |
| 5 y5 years | -814.0% | -806.7% |
CNSP Retained Earnings High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -232.1% | at low | -152.4% | at low |
| 5 y | 5 years | -814.0% | at low | -806.7% | at low |
| alltime | all time | <-9999.0% | at low | -967.5% | at low |
CNS Pharmaceuticals Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -$81.25 M(+7.4%) |
| June 2024 | - | -$75.64 M(+3.5%) |
| Mar 2024 | - | -$73.11 M(+5.1%) |
| Dec 2023 | -$69.57 M(+37.2%) | -$69.57 M(+8.4%) |
| Sept 2023 | - | -$64.19 M(+7.6%) |
| June 2023 | - | -$59.67 M(+7.2%) |
| Mar 2023 | - | -$55.65 M(+9.7%) |
| Dec 2022 | -$50.72 M(+43.1%) | -$50.72 M(+13.3%) |
| Sept 2022 | - | -$44.75 M(+8.3%) |
| June 2022 | - | -$41.33 M(+9.4%) |
| Mar 2022 | - | -$37.77 M(+6.6%) |
| Dec 2021 | -$35.44 M | -$35.44 M(+10.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2021 | - | -$32.19 M(+13.4%) |
| June 2021 | - | -$28.37 M(+15.5%) |
| Mar 2021 | - | -$24.56 M(+17.3%) |
| Dec 2020 | -$20.95 M(+82.3%) | -$20.95 M(+16.7%) |
| Sept 2020 | - | -$17.94 M(+12.6%) |
| June 2020 | - | -$15.93 M(+18.4%) |
| Mar 2020 | - | -$13.46 M(+17.1%) |
| Dec 2019 | -$11.49 M(+50.9%) | -$11.49 M(+28.2%) |
| Sept 2019 | - | -$8.96 M(+8.6%) |
| June 2019 | - | -$8.25 M(+8.5%) |
| Dec 2018 | -$7.61 M(+3369.1%) | -$7.61 M |
| Dec 2017 | -$219.40 K | - |
FAQ
- What is CNS Pharmaceuticals annual retained earnings?
- What is the all time high annual retained earnings for CNS Pharmaceuticals?
- What is CNS Pharmaceuticals annual retained earnings year-on-year change?
- What is CNS Pharmaceuticals quarterly retained earnings?
- What is the all time high quarterly retained earnings for CNS Pharmaceuticals?
- What is CNS Pharmaceuticals quarterly retained earnings year-on-year change?
What is CNS Pharmaceuticals annual retained earnings?
The current annual retained earnings of CNSP is -$69.57 M
What is the all time high annual retained earnings for CNS Pharmaceuticals?
CNS Pharmaceuticals all-time high annual retained earnings is -$219.40 K
What is CNS Pharmaceuticals annual retained earnings year-on-year change?
Over the past year, CNSP annual retained earnings has changed by -$18.85 M (-37.17%)
What is CNS Pharmaceuticals quarterly retained earnings?
The current quarterly retained earnings of CNSP is -$81.25 M
What is the all time high quarterly retained earnings for CNS Pharmaceuticals?
CNS Pharmaceuticals all-time high quarterly retained earnings is -$7.61 M
What is CNS Pharmaceuticals quarterly retained earnings year-on-year change?
Over the past year, CNSP quarterly retained earnings has changed by -$17.06 M (-26.57%)